Caisse de depot et placement du Quebec
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 898286
Montreal, A8
Position in REGN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$254,212,467
-$10,013,299 QoQ
Shares Held
329,018
-3.9% QoQ
Ownership
0.314%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Caisse de depot et placement du Quebec holds $667,145,858 across 11 Biotechnology names. REGN ranks #1 (38.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
329,018 | $254,212,467 | |
| 2 | INCY |
Incyte Corp
|
1,520,486 | $143,108,142 | |
| 3 | EXEL |
Exelixis, Inc.
|
2,542,819 | $109,061,506 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,121,200 | $72,463,156 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
945,603 | $53,417,113 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
50,917 | $22,736,477 | |
| 7 | RPRX |
Royalty Pharma plc
|
218,031 | $10,458,947 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,988 | $657,769 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $254,212,467 | 329,018 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $264,225,766 | 342,319 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $260,050,999 | 462,502 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $112,729,050 | 214,722 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $141,188,477 | 222,614 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $220,931,286 | 310,153 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $204,597,585 | 194,625 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $145,879,810 | 138,797 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $219,448,682 | 228,001 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $228,501,196 | 260,166 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $121,856,510 | 148,071 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $129,522,583 | 180,258 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $135,700,443 | 165,152 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $77,499,569 | 107,416 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $86,426,319 | 125,461 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $64,913,758 | 109,813 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $114,305,512 | 163,663 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $116,526,175 | 184,517 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $74,106,106 | 122,453 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $22,154,489 | 39,665 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,420,329 | 7,229 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $3,642,649 | 7,540 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $6,017,075 | 10,749 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $7,140,168 | 11,449 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $7,592,421 | 15,549 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||